开云app官网登录入口网页版-官方正版

#心血管结局#

116篇内容 | 3792人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2218910, encodeId=44fc2218910f5, content=<a href='/topic/show?id=2b3910085190' target=_blank style='color:#2F92EE;'>#风险#</a> <a href='/topic/show?id=e01f3e12825' target=_blank style='color:#2F92EE;'>#原发性醛固酮增多症#</a> <a href='/topic/show?id=49d1518915a' target=_blank style='color:#2F92EE;'>#心血管结局#</a>, objectTitle=JAHA：原发性醛固酮增多症与心血管结局风险的关系, objectType=article, longId=837901, objectId=90b183e901d4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240806/1722941538090_8538692.png, objectUrl=/article/show_article.do?id=90b183e901d4, replyNumber=0, likeNumber=37, createdTime=2024-08-07, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=90b183e901d4, moduleTitle=JAHA：原发性醛固酮增多症与心血管结局风险的关系, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=90b183e901d4)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2218716, encodeId=04df2218e166e, content=<a href='/topic/show?id=49d1518915a' target=_blank style='color:#2F92EE;'>#心血管结局#</a> <a href='/topic/show?id=c4ba11480956' target=_blank style='color:#2F92EE;'>#磷酸二酯酶-5抑制剂#</a>, objectTitle=Eur Heart J-Card Pha：磷酸二酯酶-5抑制剂对心血管结局和死亡率的长期影响, objectType=article, longId=837748, objectId=a99683e74839, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240805/1722828015529_8538692.png, objectUrl=/article/show_article.do?id=a99683e74839, replyNumber=0, likeNumber=51, createdTime=2024-08-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a99683e74839, moduleTitle=Eur Heart J-Card Pha：磷酸二酯酶-5抑制剂对心血管结局和死亡率的长期影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=a99683e74839)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2212421, encodeId=79e222124210c, content=<a href='/topic/show?id=737a54248f5' target=_blank style='color:#2F92EE;'>#房颤#</a> <a href='/topic/show?id=3379266918f' target=_blank style='color:#2F92EE;'>#体重增加#</a> <a href='/topic/show?id=49d1518915a' target=_blank style='color:#2F92EE;'>#心血管结局#</a>, objectTitle=JAHA：体重增加对房颤患者心血管结局的影响, objectType=article, longId=832239, objectId=885a83223915, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240628/1719587918171_5579292.png, objectUrl=/article/show_article.do?id=885a83223915, replyNumber=0, likeNumber=67, createdTime=2024-06-30, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=885a83223915, moduleTitle=JAHA：体重增加对房颤患者心血管结局的影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=885a83223915)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2206383, encodeId=ca6c22063837f, content=<a href='/topic/show?id=49d1518915a' target=_blank style='color:#2F92EE;'>#心血管结局#</a> <a href='/topic/show?id=c4ba11480956' target=_blank style='color:#2F92EE;'>#磷酸二酯酶-5抑制剂#</a>, objectTitle=Eur Heart J-Card Pha：磷酸二酯酶-5抑制剂对心血管结局和死亡的长期影响, objectType=article, longId=827226, objectId=3f4582e22601, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240523/1716476376293_5579292.png, objectUrl=/article/show_article.do?id=3f4582e22601, replyNumber=0, likeNumber=67, createdTime=2024-05-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=3f4582e22601, moduleTitle=Eur Heart J-Card Pha：磷酸二酯酶-5抑制剂对心血管结局和死亡的长期影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3f4582e22601)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2200493, encodeId=bb982200493eb, content=<a href='/topic/show?id=cd9b52640dd' target=_blank style='color:#2F92EE;'>#性别差异#</a> <a href='/topic/show?id=49d1518915a' target=_blank style='color:#2F92EE;'>#心血管结局#</a> <a href='/topic/show?id=ca77113822c5' target=_blank style='color:#2F92EE;'>#老年迟发性高血压#</a>, objectTitle=Hypertension：老年迟发性高血压患者心血管结局的性别差异, objectType=article, longId=823289, objectId=35df82328915, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240425/1714048849068_1739456.jpg, objectUrl=/article/show_article.do?id=35df82328915, replyNumber=0, likeNumber=81, createdTime=2024-04-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=35df82328915, moduleTitle=Hypertension：老年迟发性高血压患者心血管结局的性别差异, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=35df82328915)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2193326, encodeId=bd8221933269a, content=<a href='/topic/show?id=012453653b8' target=_blank style='color:#2F92EE;'>#慢性肾脏疾病#</a> <a href='/topic/show?id=3ba65014911' target=_blank style='color:#2F92EE;'>#强化降压目标#</a> <a href='/topic/show?id=49d1518915a' target=_blank style='color:#2F92EE;'>#心血管结局#</a>, objectTitle=JAHA：慢性肾脏疾病患者强化降压目标与心血管结局的关联, objectType=article, longId=817133, objectId=fb8b81e1330c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240314/1710425718411_1739456.jpg, objectUrl=/article/show_article.do?id=fb8b81e1330c, replyNumber=0, likeNumber=101, createdTime=2024-03-15, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=fb8b81e1330c, moduleTitle=JAHA：慢性肾脏疾病患者强化降压目标与心血管结局的关联, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=fb8b81e1330c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2179604, encodeId=f77021e9604be, content=<a href='/topic/show?id=e051501461d' target=_blank style='color:#2F92EE;'>#强化降压#</a> <a href='/topic/show?id=5e61e13494d' target=_blank style='color:#2F92EE;'>#癌症幸存者#</a> <a href='/topic/show?id=49d1518915a' target=_blank style='color:#2F92EE;'>#心血管结局#</a>, objectTitle=Hypertension：强化降压对癌症幸存者心血管结局的影响, objectType=article, longId=808400, objectId=29b480840078, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240105/1704453965761_1739456.jpg, objectUrl=/article/show_article.do?id=29b480840078, replyNumber=0, likeNumber=79, createdTime=2024-01-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=29b480840078, moduleTitle=Hypertension：强化降压对癌症幸存者心血管结局的影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=29b480840078)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2089252, encodeId=bf182089252e4, content=这是典型的“万病归心”的一种，<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>专家开始关心<a href='/topic/show?id=df1582921da' target=_blank style='color:#2F92EE;'>#肿瘤心脏病学#</a>，糖尿病专家现在关心<a href='/topic/show?id=49d1518915a' target=_blank style='color:#2F92EE;'>#心血管结局#</a>，如<a href='/topic/show?id=f5cb5192610' target=_blank style='color:#2F92EE;'>#心衰#</a>等，同样<a href='/topic/show?id=e2d110081540' target=_blank style='color:#2F92EE;'>#风湿免疫#</a>也关心<a href='/topic/show?id=38c451e4317' target=_blank style='color:#2F92EE;'>#心血管事件#</a>，如<a href='/topic/show?id=69bbe11620e' target=_blank style='color:#2F92EE;'>#痛风#</a><a href='/topic/show?id=7face61750b' target=_blank style='color:#2F92EE;'>#类风湿性关节炎#</a>的心血管预后是大家关心的，这是大趋势。这是<a href='/topic/show?id=09e5300311a' target=_blank style='color:#2F92EE;'>#共病#</a>或伴随疾病。同样，从治疗上也可能有相互借鉴的可能，如<a href='/topic/show?id=10d5e476742' target=_blank style='color:#2F92EE;'>#秋水仙碱#</a>用于心血管疾病，有望成为下一代神药。同样，其它治疗风湿类疾病的药物，是不是也有此潜力？？大家可以联想一下，打开思路, objectTitle=JAHA：风湿性免疫介导的炎症性疾病患者急性冠脉综合征预后分析, objectType=article, longId=740031, objectId=0678e400311c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220919/1663582471640_1739456.jpg, objectUrl=/article/show_article.do?id=0678e400311c, replyNumber=0, likeNumber=220, createdTime=2022-09-20, rootId=0, userName=小小医者, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0678e400311c, moduleTitle=JAHA：风湿性免疫介导的炎症性疾病患者急性冠脉综合征预后分析, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0678e400311c)], followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=1269414, encodeId=9e1812694142d, content=<a href='/topic/show?id=49d1518915a' target=_blank style='color:#2F92EE;'>#心血管结局#</a>, objectTitle=Circulation：早期心律控制有助于减少多合并症的新发房颤患者的心血管结局, objectType=article, longId=739502, objectId=7f5ce3950226, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f5ce3950226, replyNumber=0, likeNumber=109, createdTime=2022-09-18, rootId=0, userName=gous, userId=7a9987, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f5ce3950226, moduleTitle=Circulation：早期心律控制有助于减少多合并症的新发房颤患者的心血管结局, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7f5ce3950226)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1269413, encodeId=8dbf126941303, content=<a href='/topic/show?id=49d1518915a' target=_blank style='color:#2F92EE;'>#心血管结局#</a>, objectTitle=JAHA：急性冠状动脉综合征和阻塞性睡眠呼吸暂停患者的ANGPTL3与心血管结局的关系, objectType=article, longId=739125, objectId=38cce3912579, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38cce3912579, replyNumber=0, likeNumber=108, createdTime=2022-09-14, rootId=0, userName=gous, userId=7a9987, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38cce3912579, moduleTitle=JAHA：急性冠状动脉综合征和阻塞性睡眠呼吸暂停患者的ANGPTL3与心血管结局的关系, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=38cce3912579)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1269412, encodeId=3afd126941241, content=<a href='/topic/show?id=49d1518915a' target=_blank style='color:#2F92EE;'>#心血管结局#</a>, objectTitle=“二甲双胍+胰岛素”vs“二甲双胍+磺脲类药物”，谁的降糖疗效和心血管结局更好？, objectType=article, longId=737817, objectId=8bdfe378177c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8bdfe378177c, replyNumber=0, likeNumber=124, createdTime=2022-09-06, rootId=0, userName=gous, userId=7a9987, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8bdfe378177c, moduleTitle=“二甲双胍+胰岛素”vs“二甲双胍+磺脲类药物”，谁的降糖疗效和心血管结局更好？, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=8bdfe378177c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1269411, encodeId=7d411269411bc, content=<a href='/topic/show?id=49d1518915a' target=_blank style='color:#2F92EE;'>#心血管结局#</a>, objectTitle=ESC 2022：痛风药物别嘌呤醇跨界失败，不改善缺血性心脏病的心血管结局（ALL-HEART研究）, objectType=article, longId=737196, objectId=6528e37196c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6528e37196c0, replyNumber=0, likeNumber=128, createdTime=2022-08-29, rootId=0, userName=gous, userId=7a9987, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6528e37196c0, moduleTitle=ESC 2022：痛风药物别嘌呤醇跨界失败，不改善缺血性心脏病的心血管结局（ALL-HEART研究）, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6528e37196c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1269410, encodeId=f98012694104f, content=<a href='/topic/show?id=49d1518915a' target=_blank style='color:#2F92EE;'>#心血管结局#</a>, objectTitle=Hypertension：较高和较低手臂收缩压与心血管结局之间的关系, objectType=article, longId=734373, objectId=42e5e34373f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42e5e34373f9, replyNumber=0, likeNumber=110, createdTime=2022-08-05, rootId=0, userName=gous, userId=7a9987, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42e5e34373f9, moduleTitle=Hypertension：较高和较低手臂收缩压与心血管结局之间的关系, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=42e5e34373f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1269409, encodeId=904d126940979, content=<a href='/topic/show?id=49d1518915a' target=_blank style='color:#2F92EE;'>#心血管结局#</a>, objectTitle=JAHA：高敏肌钙蛋白T和I浓度与CAD患者全因死亡率和心血管结局的关联, objectType=article, longId=732874, objectId=d436e3287476, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d436e3287476, replyNumber=0, likeNumber=151, createdTime=2022-07-22, rootId=0, userName=gous, userId=7a9987, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d436e3287476, moduleTitle=JAHA：高敏肌钙蛋白T和I浓度与CAD患者全因死亡率和心血管结局的关联, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d436e3287476)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1269408, encodeId=8c90126940865, content=<a href='/topic/show?id=49d1518915a' target=_blank style='color:#2F92EE;'>#心血管结局#</a>, objectTitle=ARD：托法替布与心血管结局风险：托法替布在类风湿关节炎常规护理患者中的安全性(STAR-RA)研究结果, objectType=article, longId=730642, objectId=e9f6e3064209, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9f6e3064209, replyNumber=0, likeNumber=103, createdTime=2022-06-29, rootId=0, userName=gous, userId=7a9987, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9f6e3064209, moduleTitle=ARD：托法替布与心血管结局风险：托法替布在类风湿关节炎常规护理患者中的安全性(STAR-RA)研究结果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e9f6e3064209)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1269407, encodeId=949c126940e2f, content=<a href='/topic/show?id=49d1518915a' target=_blank style='color:#2F92EE;'>#心血管结局#</a>, objectTitle=JAHA：钠摄入量与粒细胞、肾脏和心血管结局的关系, objectType=article, longId=730442, objectId=f7aee3044246, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f7aee3044246, replyNumber=0, likeNumber=114, createdTime=2022-06-26, rootId=0, userName=gous, userId=7a9987, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f7aee3044246, moduleTitle=JAHA：钠摄入量与粒细胞、肾脏和心血管结局的关系, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f7aee3044246)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1269406, encodeId=387d1269406f2, content=<a href='/topic/show?id=49d1518915a' target=_blank style='color:#2F92EE;'>#心血管结局#</a>, objectTitle=JACC：不同主动脉病变患者心血管结局, objectType=article, longId=728175, objectId=ef4ee28175c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef4ee28175c3, replyNumber=0, likeNumber=107, createdTime=2022-05-31, rootId=0, userName=gous, userId=7a9987, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef4ee28175c3, moduleTitle=JACC：不同主动脉病变患者心血管结局, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ef4ee28175c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1269405, encodeId=ea9d1269405dc, content=<a href='/topic/show?id=49d1518915a' target=_blank style='color:#2F92EE;'>#心血管结局#</a>, objectTitle=Ann Intern Med：钠-葡萄糖协同转运蛋白-2抑制剂与二甲双胍治疗2型糖尿病患者的心血管结局比较, objectType=article, longId=728165, objectId=9339e28165c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9339e28165c0, replyNumber=0, likeNumber=114, createdTime=2022-05-31, rootId=0, userName=gous, userId=7a9987, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9339e28165c0, moduleTitle=Ann Intern Med：钠-葡萄糖协同转运蛋白-2抑制剂与二甲双胍治疗2型糖尿病患者的心血管结局比较, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9339e28165c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1269403, encodeId=2a0c1269403aa, content=<a href='/topic/show?id=49d1518915a' target=_blank style='color:#2F92EE;'>#心血管结局#</a>, objectTitle=Thorax：持续气道正压通气治疗对阻塞性睡眠呼吸暂停的心血管结局和临床表型的影响, objectType=article, longId=301383, objectId=cf853013836a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf853013836a, replyNumber=0, likeNumber=119, createdTime=2022-03-23, rootId=0, userName=gous, userId=7a9987, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf853013836a, moduleTitle=Thorax：持续气道正压通气治疗对阻塞性睡眠呼吸暂停的心血管结局和临床表型的影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=cf853013836a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1269402, encodeId=82d1126940225, content=<a href='/topic/show?id=49d1518915a' target=_blank style='color:#2F92EE;'>#心血管结局#</a>, objectTitle=Arthritis Rheumatol：银屑病关节炎和银屑病患者心脏生物标志物与心血管结局的关联, objectType=article, longId=300568, objectId=e338300568d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e338300568d1, replyNumber=0, likeNumber=110, createdTime=2022-03-13, rootId=0, userName=gous, userId=7a9987, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e338300568d1, moduleTitle=Arthritis Rheumatol：银屑病关节炎和银屑病患者心脏生物标志物与心血管结局的关联, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e338300568d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

心血管结局

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#风险# #原发性醛固酮增多症# #心血管结局#

JAHA：原发性醛固酮增多症与心血管结局风险的关系

2024-08-07发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#心血管结局# #磷酸二酯酶-5抑制剂#

Eur Heart J-Card Pha：磷酸二酯酶-5抑制剂对心血管结局和死亡率的长期影响

2024-08-06发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#房颤# #体重增加# #心血管结局#

JAHA：体重增加对房颤患者心血管结局的影响

2024-06-30发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#心血管结局# #磷酸二酯酶-5抑制剂#

Eur Heart J-Card Pha：磷酸二酯酶-5抑制剂对心血管结局和死亡的长期影响

2024-05-24发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#性别差异# #心血管结局# #老年迟发性高血压#

Hypertension：老年迟发性高血压患者心血管结局的性别差异

2024-04-26发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#慢性肾脏疾病# #强化降压目标# #心血管结局#

JAHA：慢性肾脏疾病患者强化降压目标与心血管结局的关联

2024-03-15发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#强化降压# #癌症幸存者# #心血管结局#

Hypertension：强化降压对癌症幸存者心血管结局的影响

2024-01-06发表于上海

小小医者 (审核中...)

前往app查看评论内容

全文收起这是典型的“万病归心”的一种，#肿瘤#专家开始关心#肿瘤心脏病学#，糖尿病专家现在关心#心血管结局#，如#心衰#等，同样#风湿免疫#也关心#心血管事件#，如#痛风##类风湿性关节炎#的心血管预后是大家关心的，这是大趋势。这是#共病#或伴随疾病。同样，从治疗上也可能有相互借鉴的可能，如#秋水仙碱#用于心血管疾病，有望成为下一代神药。同样，其它治疗风湿类疾病的药物，是不是也有此潜力？？大家可以联想一下，打开思路

JAHA：风湿性免疫介导的炎症性疾病患者急性冠脉综合征预后分析

2022-09-20

gous (审核中...)

前往app查看评论内容

#心血管结局#

Circulation：早期心律控制有助于减少多合并症的新发房颤患者的心血管结局

2022-09-18

gous (审核中...)

前往app查看评论内容

#心血管结局#

JAHA：急性冠状动脉综合征和阻塞性睡眠呼吸暂停患者的ANGPTL3与心血管结局的关系

2022-09-14

gous (审核中...)

前往app查看评论内容

#心血管结局#

“二甲双胍+胰岛素”vs“二甲双胍+磺脲类药物”，谁的降糖疗效和心血管结局更好？

2022-09-06

gous (审核中...)

前往app查看评论内容

#心血管结局#

ESC 2022：痛风药物别嘌呤醇跨界失败，不改善缺血性心脏病的心血管结局（ALL-HEART研究）

2022-08-29

gous (审核中...)

前往app查看评论内容

#心血管结局#

Hypertension：较高和较低手臂收缩压与心血管结局之间的关系

2022-08-05

gous (审核中...)

前往app查看评论内容

#心血管结局#

JAHA：高敏肌钙蛋白T和I浓度与CAD患者全因死亡率和心血管结局的关联

2022-07-22

gous (审核中...)

前往app查看评论内容

#心血管结局#

ARD：托法替布与心血管结局风险：托法替布在类风湿关节炎常规护理患者中的安全性(STAR-RA)研究结果

2022-06-29

gous (审核中...)

前往app查看评论内容

#心血管结局#

JAHA：钠摄入量与粒细胞、肾脏和心血管结局的关系

2022-06-26

gous (审核中...)

前往app查看评论内容

#心血管结局#

JACC：不同主动脉病变患者心血管结局

2022-05-31

gous (审核中...)

前往app查看评论内容

#心血管结局#

Ann Intern Med：钠-葡萄糖协同转运蛋白-2抑制剂与二甲双胍治疗2型糖尿病患者的心血管结局比较

2022-05-31

gous (审核中...)

前往app查看评论内容

#心血管结局#

Thorax：持续气道正压通气治疗对阻塞性睡眠呼吸暂停的心血管结局和临床表型的影响

2022-03-23

gous (审核中...)

前往app查看评论内容

#心血管结局#

Arthritis Rheumatol：银屑病关节炎和银屑病患者心脏生物标志物与心血管结局的关联

2022-03-13

科室
- - 订阅+
  - 更多科室
工具
服务